Company Name | Orexo |
---|---|
Website | https://orexo.com |
Snippet | Orexo launches deprexis® and vorvida® in the US and provides updated financial guidance Jul 2 2020 Number of shares and votes in Orexo May 29 2020 News. Invitation to presentation of the Interim Report Q2 2020, on July 16 at 3 pm CET Jul 8 2020 Gesynta Pharma raises SEK 190 million and will initiate a phase 2 study for OX-MPI in Q4 ... |
ISIN | SE0000736415 |
Type | Public |
Founded | 1995 |
Revenue | SEK 429.4 million (2013)[1] |
Website | Orexo.com |
Industry | Pharmaceutical |
Products | See list |
Traded as | Nasdaq Stockholm: ORX |
Key people | Nikolaj Sørensen(CEO) |
Net income | SEK 154.9 million (2013)[1] |
Area served | Worldwide |
Headquarters | Uppsala, Sweden |
Number of employees | 108 (2013) [1] |
Orexo is part of the Sweden company list
Have a list of company names and need to update information? Use our Company Search tool.
Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.
Want to update this profile? Please contact us here with a link to the public source verifying the edit.
Powrbot Inc. is a passionate company working on problems using data analytics, automation & machine learning. Our goal is to automate the boring stuff.
Contact Us